Buy Divi's Laboratories, target price Rs 3874: BNP Paribas
Divi's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Scrap, Export Incentives and Contract Fees for the year ending 31-Mar-2022.

Divi's Laboratories Ltd., incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 87753.29 Crore) operating in Pharmaceuticals sector.
Divi's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Scrap, Export Incentives and Contract Fees for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-09-2022, the company reported a Consolidated Total Income of Rs 1934.62 Crore, down -17.43 % from last quarter Total Income of Rs 2342.91 Crore and down -3.59 % from last year same quarter Total Income of Rs 2006.62 Crore. Company reported net profit after tax of Rs 493.60 Crore in latest quarter.
Promoter/FII Holdings
Promoters held 51.94 per cent stake in the company as of 30-Sep-2022, while FIIs owned 22.1 per cent, DIIs 20.64 per cent.
Download ET Markets APP